These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26442843)

  • 1. The History of Patenting Genetic Material.
    Sherkow JS; Greely HT
    Annu Rev Genet; 2015; 49():161-82. PubMed ID: 26442843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invalidating human gene patenting: the U.S. Supreme Court rules in Association for Molecular Pathology v. Myriad Genetics.
    Kalyvas J; Little AS
    World Neurosurg; 2013 Dec; 80(6):680-1. PubMed ID: 24134909
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene patents, patenting life and the impact of court rulings on US stem cell patents and research.
    Matthews KR; Cuchiara ML
    Regen Med; 2014 Mar; 9(2):191-200. PubMed ID: 24750060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human genes patents: yes or no? Reflections on the ruling of the Supreme Court of the United States].
    Lacadena JR
    Rev Derecho Genoma Hum; 2013; (38):167-81. PubMed ID: 24340831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The
    Sherkow JS; Cook-Deegan R; Greely HT
    Annu Rev Genomics Hum Genet; 2024 Aug; 25(1):397-419. PubMed ID: 38424474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene patenting--is the pendulum swinging back?
    Kesselheim AS; Mello MM
    N Engl J Med; 2010 May; 362(20):1855-8. PubMed ID: 20375396
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers.
    Cook-Deegan R; DeRienzo C; Carbone J; Chandrasekharan S; Heaney C; Conover C
    Genet Med; 2010 Apr; 12(4 Suppl):S15-38. PubMed ID: 20393305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
    Offit K; Bradbury A; Storm C; Merz JF; Noonan KE; Spence R
    J Clin Oncol; 2013 Jul; 31(21):2743-8. PubMed ID: 23766521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseball bats and chocolate chip cookies: the judicial treatment of DNA in the myriad genetics litigation.
    Binnie I; Park-Thompson V
    Cold Spring Harb Perspect Med; 2014 Dec; 5(6):. PubMed ID: 25524722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care?
    Chandrasekharan S; McGuire AL; Van den Veyver IB
    Prenat Diagn; 2014 Oct; 34(10):921-6. PubMed ID: 24989832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYRIAD VOICES AGAINST GENE PATENTS IN THE HIGH COURT.
    McCallum L; Faunce T
    J Law Med; 2015 Dec; 23(2):322-9. PubMed ID: 26939499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Divergence in Gene Patenting.
    Nicol D; Dreyfuss RC; Gold ER; Li W; Liddicoat J; Van Overwalle G
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():519-541. PubMed ID: 30786226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myriad and the mass media: the covering of a gene patent controversy.
    Caulfield T; Bubela T; Murdoch CJ
    Genet Med; 2007 Dec; 9(12):850-5. PubMed ID: 18091435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of gene patents and the implications for medicine.
    Sherkow JS; Greely HT
    JAMA Intern Med; 2013 Sep; 173(17):1569-70. PubMed ID: 23896757
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenging gene patents. Myriad ruling will impact personalized medicine.
    Lee J
    Mod Healthc; 2013 Apr; 43(15):8-9. PubMed ID: 23738477
    [No Abstract]   [Full Text] [Related]  

  • 17. [Opposition to Myriad Genetics patents and their total or partial revocation in Europe: early conclusions].
    Cassier M; Stoppa-Lyonnet D
    Med Sci (Paris); 2005; 21(6-7):658-62. PubMed ID: 15985212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Battle brewing over the BRCA1/2 gene patents.
    Agovic A
    Rev Derecho Genoma Hum; 2010; (33):171-94. PubMed ID: 21510137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supreme Court of the United States syllabus. Association for Molecular Pathology et ál. v. Myriad Genetics, Inc., et al. certiorari to the United States Court of Appeals for the Federal Circuit.
    Rev Derecho Genoma Hum; 2013; (38):217-9. PubMed ID: 24340833
    [No Abstract]   [Full Text] [Related]  

  • 20. The patent is political: the consequences of patenting the BRCA genes in Britain.
    Parthasarathy S
    Community Genet; 2005; 8(4):235-42. PubMed ID: 16244478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.